“ConclusionsAntioxidant effect Vitamin E and telmisartan) have been shown to decrease doxorubicininduced cardiotoxicity.”
“ Doxorubicin treatment increased MDA, LDH, CK-MB levels significantly (P < 0.01), and were counteracted by administration of vitamin E and telmisartan, but did not significantly affect serum catalase activity.”